Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease
Wakefield, A.J.; Hudson, M.; Pounder, R.E.
Advances in Experimental Medicine and Biology 371b: 1307-1311
1995
ISSN/ISBN: 0065-2598 PMID: 7502806 Document Number: 440622
Document emailed within 1 workday
Related Documents
Howell, J.G.; Zibari, G.B.; Brown, M.F.; Burney, D.L.; Sawaya, D.E.; Olinde, J.G.; Granger, D.N.; McDonald, J.C. 2000: Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions Transplantation 69(2): 300-303Lombardini, R.; Vaudo, G.; Ciuffetti, G. 1997: Leukocyte-endothelial cell interactions and vascular injury in the earliest preclinical stages of atherosclerosis Haematologica 82(2): 253
Steinhart, A.H.; Hemphill, D.; Greenberg, G.R. 1994: Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis American Journal of Gastroenterology 89(12): 2116-2124
Sinico, R.A.; Sabadini, E.; Maresca, A.M. 2006: Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis Clinical and Experimental Rheumatology 24(2 Suppl 41: S104
Tromm, A.; Griga, T.; May, B. 1999: Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties Hepato-Gastroenterology 46(30): 3124-3135
Ushiyama, A.; Masuda, H.; Hirota, S.; Ohkubo, C. 2004: Subchronic effects on leukocyte-endothelial interactions in mice by whole body exposure to extremely low frequency electromagnetic fields In Vivo 18(4): 425-432
Keizer, G.D.; Visser, W.; Vliem, M.; Figdor, C.G. 1988: A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions Journal of Immunology 140(5): 1393-1400
Mor, F.; Reizis, B.; Cohen, I.R.; Steinman, L. 1996: IL-2 and TNF receptors as targets of regulatory T-T interactions: isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat Journal of Immunology 157(11): 4855-4861
Küchenhoff, J. 1995: Bio-psychosocial interactions in follow-up of Crohn disease Zeitschrift für Psychosomatische Medizin und Psychoanalyse 41(4): 306-328
Kurtel, H.; Liao, L.; Grisham, M.B.; Tso, P.; Aw, T.Y.; Anderson, D.C.; Miyasaka, M.; Granger, D.N. 1995: Mechanisms of oxidized chylomicron-induced leukocyte-endothelial cell adhesion American Journal of Physiology 268(6 Pt 2): H2175-H2182
Willoughby, J.M.; Mitchell, D. 1971: Effect of sarcoid spleen suspension on in vitro leukocyte migration in Crohn's disease Gut 12(6): 496
Winn, R.; Vedder, N.; Ramamoorthy, C.; Sharar, S.; Harlan, J. 1998: Endothelial and leukocyte adhesion molecules in inflammation and disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(Suppl 2): S17-S23
Briscoe, D.M.; Cotran, R.S. 1993: Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: in vitro and in vivo studies Kidney International. Suppl 42: S27-S34
Kaplan, S.S.; Basford, R.E.; Boggs, S.S.; Zdziarski, U.E. 1982: Platelet leukocyte interactions. II. In-vivo correction of Chediak-Higashi leukocyte function with serotonin or normal platelets Advances in Experimental Medicine and Biology 141: 519-530
Xiao, X.; Ma, X.; Liu, L.; Wang, J.; Bi, K.; Liu, Y.; Fan, R.; Zhao, B.; Chen, Y.; Bihl, J.C. 2015: Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease Current Vascular Pharmacology 13(4): 449-458
Hézard, N.; Metz, D.; Garnotel, R.; Droullé, C.; Potron, G.; Nguyen, P. 2000: Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation Journal des Maladies Vasculaires 25(5): 343-348
Goebell, H.; Wienbeck, M.; Schomerus, H.; Malchow, H. 1990: Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study Medizinische Klinik 85(10): 573-576
Bastida, E.; Almirall, L.; Ordinas, A.; Buchanan, M.R.; Orr, F.W.; Bertomeu, M.C.; Haas, T.A. 1991: Effects of endothelial cell treatment on 13-HODE and prostacyclin synthesis and its correlation with tumor cell-vascular endothelial cell adhesion Invasion and Metastasis 11(5): 273-280
Ivancević, V. 1996: Falsely negative 99mTc-anti-granulocyte immunoscintigraphy and positive 99mTc-HMPAO labelled leukocyte scan in active Crohn's disease Nuklearmedizin. Nuclear Medicine 35(4): 55
Marafioti, T.; Mancini, C.; Ascani, S.; Sabattini, E.; Zinzani, P.Luigi.; Pozzobon, M.; Pulford, K.; Falini, B.; Jaffe, E.S.; Müller-Hermelink, H-Konrad.; Mason, D.Y.; Pileri, S.A. 2004: Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease Haematologica 89(8): 957-964